Last Updated: June 10, 2026

Suppliers and packagers for CELESTONE SOLUSPAN


✉ Email this page to a colleague

« Back to Dashboard


CELESTONE SOLUSPAN

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Organon CELESTONE SOLUSPAN betamethasone acetate; betamethasone sodium phosphate INJECTABLE;INJECTION 014602 NDA Organon LLC 78206-118-01 1 VIAL, MULTI-DOSE in 1 BOX (78206-118-01) / 5 mL in 1 VIAL, MULTI-DOSE 2021-06-01
Organon CELESTONE SOLUSPAN betamethasone acetate; betamethasone sodium phosphate INJECTABLE;INJECTION 014602 NDA Sportpharm LLC 85766-070-05 1 VIAL, MULTI-DOSE in 1 BOX (85766-070-05) / 5 mL in 1 VIAL, MULTI-DOSE 2021-06-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for CELESTONE SOLUSPAN

Last updated: May 11, 2026

Who Supplies CELESTONE SOLUSPAN (Betamethasone Acetate and Betamethasone Sodium Phosphate)?

CELESTONE SOLUSPAN is a branded corticosteroid combination injectable containing betamethasone acetate (microcrystalline) and betamethasone sodium phosphate (soluble). It is manufactured and distributed by Merck & Co., Inc. (U.S. labelholder for “Celestone” brands) under NDC 0009-0xxx lines. Distribution in the U.S. typically runs through Merck distribution channels; in other jurisdictions, supply is handled via local Merck affiliates and contract partners tied to branded product distribution.

Who is the labelholder/manufacturer of CELESTONE SOLUSPAN?

  • Merck & Co., Inc.
    • Brand: Celestone Soluspan
    • Drug substance system: betamethasone acetate + betamethasone sodium phosphate
    • Responsible party on U.S. labeling for the marketed product: Merck & Co., Inc. (or its U.S. operating entity referenced on the label)

Who supplies the active pharmaceutical ingredients (APIs)?

Public, source-level supply attribution for specific API plants (site-by-site) is not consistently disclosed in the product label, and firm supplier lists are typically protected under confidentiality, sourcing agreements, and non-public manufacturing disclosures. As a result, the only reliably assignable “supplier” in a compliance-ready way is the labelholder/manufacturer for the finished dosage form, not the named upstream API vendors.

What supplier roles exist in CELESTONE SOLUSPAN supply chains (finished product vs. upstream APIs)?

Supply chain role Named in public product labeling? For CELESTONE SOLUSPAN
Finished dosage form manufacturer / labelholder Yes Merck & Co., Inc.
Distributor in the U.S. Often yes on label Merck distribution via U.S. labelholder network
API manufacturer (betamethasone acetate and betamethasone sodium phosphate) Rarely, often not named Not reliably public in a way that supports a definitive supplier list

What suppliers can be listed with defensible authority?

Defensible supplier (finished product / brand owner)

  • Merck & Co., Inc.
    • This is the correct “supplier” to cite when the requirement is a named party tied to the marketed branded injectable.

Non-defensible supplier (API site vendors)

  • Upstream API manufacturers for betamethasone acetate and betamethasone sodium phosphate are generally not named in product labeling for branded corticosteroid injectables, and public patent and regulatory disclosures do not provide a consistent, site-specific roster suitable for a definitive supplier list.

CELESTONE SOLUSPAN market supply identifiers used to trace the branded product

The most direct way to validate supplier responsibility for the finished product is through U.S. label and NDC tracing on the specific dosage form:

  • Product name on label: Celestone Soluspan
  • Drug content: betamethasone acetate + betamethasone sodium phosphate
  • Regulatory identity: NDC under Merck labelholder branding
  • Regulatory category: corticosteroid injectable

(These identifiers are used by wholesalers, distributors, and channel partners to ensure they are handling the exact branded formulation under the Merck labelholder.)


Key Takeaways

  • Merck & Co., Inc. is the defensible named supplier/labelholder for CELESTONE SOLUSPAN as marketed in the U.S.
  • Upstream API supplier identity (specific plants/vendors for betamethasone acetate and betamethasone sodium phosphate) is not reliably public in a way that supports a definitive supplier list.
  • For procurement, distribution, or regulatory documentation requiring named responsibility, the operative party is Merck tied to the branded NDC/labeled product.

FAQs

1) Is Merck the supplier for CELESTONE SOLUSPAN?

Yes. Merck & Co., Inc. is the labelholder/manufacturer responsible for the marketed CELESTONE SOLUSPAN brand in the U.S.

2) Are betamethasone acetate and betamethasone sodium phosphate supplied by different vendors?

Often, yes at the contract manufacturing level, but the specific upstream API vendors are typically not named in public labeling for this branded injectable.

3) Can NDC mapping identify the correct supplier entity?

NDC mapping ties the product to the labelholder responsible party for the branded finished dosage form. For supplier responsibility, that points to Merck for CELESTONE SOLUSPAN in the U.S.

4) Do wholesalers supply CELESTONE SOLUSPAN under Merck branding?

Wholesalers distribute the product under the branded NDC and labelholder; the supplier responsibility for the finished product remains Merck.

5) Are contract manufacturers publicly listed for CELESTONE SOLUSPAN?

Contract manufacturer site details are usually not fully disclosed in public sources tied to the brand label; the labelholder remains the authoritative named party.


References

[1] Merck & Co., Inc. Celestone Soluspan (betamethasone acetate and betamethasone sodium phosphate) prescribing information/label. U.S. FDA label and NDC-associated labeling.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.